Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Benzonatate is a non-narcotic antitussive agent primarily utilized for the symptomatic relief of cough associated with various respiratory conditions. Its chemical identity is defined by the molecular formula C18H29NO3 and it is cataloged under the CAS number 137-60-4. Structurally, this compound belongs to the class of benzoic acid esters, specifically designed to act as a local anesthetic on the stretch receptors located within the respiratory tract, particularly in the lungs and pleura. By numbing these sensory nerve endings, Benzonatate effectively interrupts the cough reflex arc at its source, thereby reducing the frequency and intensity of coughing without depressing the central nervous system or causing significant sedation, which distinguishes it from opioid-based antitussives like codeine.
The drug is commonly prescribed for acute and chronic coughs resulting from infections such as bronchitis, pneumonia, or influenza, as well as for managing coughs linked to upper respiratory tract irritations. It is available in capsule form, typically dosed according to patient age and severity of symptoms, with strict adherence to recommended limits due to potential toxicity if chewed or crushed before ingestion. While generally well-tolerated, side effects may include drowsiness, headache, nausea, and constipation. Rare but serious adverse reactions can involve hypersensitivity responses or seizures, emphasizing the need for careful administration.
Benzonatate offers a valuable therapeutic option for patients requiring effective cough suppression without the risks of addiction or respiratory depression associated with narcotic alternatives. Its mechanism of action makes it particularly suitable for individuals where suppressing the urge to cough is critical for healing or comfort, yet maintaining alertness is necessary for daily activities. Clinicians often prefer this agent for pediatric and adult populations alike, provided dosage guidelines are strictly followed. As with all medications, patients should consult healthcare providers to ensure suitability based on their medical history and concurrent medication use, ensuring safe and effective management of cough-related distress.